NovaScan
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $8M
Investors
- 6
About NovaScan
Founded in 2001 and based in Chicago, US, NovaScan, Inc. operates as a clinical-stage oncology company that develops solutions for cancer detection and treatment. In November 2021, NovaScan, Inc. The company has developed several technology platforms for cancer detection. The technology developed by the company includes cole relaxation frequency, platform technology, predictive technology, novascan marginScan™ skin device, biopsyscan™ breast biopsy, targeted drug delivery, novascan fastscan™ probe, and electrical mammogram.
Who invested in NovaScan
6 investors across 1 round
See all investors in NovaScan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 17, 2021
Amount
$8M
Investors
Questions about NovaScan
Who invested in NovaScan?
NovaScan has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NovaScan raised?
NovaScan has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NovaScan last raise money?
NovaScan's most recent round on record is a Series B, in Nov 2021.
What does NovaScan do?
Founded in 2001 and based in Chicago, US, NovaScan, Inc.
Where is NovaScan headquartered?
NovaScan is headquartered in Chicago, US.
Which VCs invest in companies like NovaScan?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NovaScan's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like NovaScan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.